BACE1 and Alzheimer disease: Currently, BACE1-AS has been verified to remain in a state of up-regulated expression in nerve tissue when a person has AD, and there are considerable differences in the distribution and concentration of BACE1-AS in plasma or plasma-derived exosomes between AD patients and healthy controls.